Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
- Abstract
- The incidence of colorectal cancer (CRC) has increased. CRC is the third most common cancer and the fourth most common cause of cancer-related deaths in Korea. Palliative chemotherapy can be used to shrink tumors and ease symptoms caused by the cancer when cure is not possible. It is important to identify chemotherapeutic agents that can be used to effectively treat metastatic CRC (mCRC) and thus improve the survival and quality of life of patients with mCRC. This review aimed to evaluate the recent developments in palliative chemotherapy for mCRC and the biological or targeted agents used based on genetic alterations.
- All Author(s)
- S. K. Baek
; K. T. Lee
; S. B. Bae
; S. C. Lee
- Issued Date
- 2019
- Type
- Article
- Keyword
- Palliative; Chemothreapy; Metastatic colorectal cancer; Survival
- Publisher
- 대한내과학회
Korean Association of Internal Medicine
- ISSN
- 1226-3303
; 2005-6648
- Citation Title
- The Korean journal of internal medicine
- Citation Volume
- 34
- Citation Number
- 6
- Citation Start Page
- 1188
- Citation End Page
- 1196
- Language(ISO)
- eng
- DOI
- 10.3904/kjim.2019.071
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/3241
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.